cefuzonam 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| antibiotics, cefalosporanic acid derivatives | 3077 | 82219-78-1 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
article gives L-105 as synonym, however L 105 is a rifamycin derivative according to Chemline
|
Drug dosage:
None
ADMET properties:
| Property | Value | Reference |
|---|---|---|
| Vd (Volume of distribution) | 0.20 L/kg | Lombardo F, Berellini G, Obach RS |
| CL (Clearance) | 4.10 mL/min/kg | Lombardo F, Berellini G, Obach RS |
| fu (Fraction unbound in plasma) | 0.12 % | Lombardo F, Berellini G, Obach RS |
| t_half (Half-life) | 1.14 hours | Lombardo F, Berellini G, Obach RS |
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| CHEBI has role | CHEBI:36047 | antibacterial drugs |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 2.29 | acidic |
| pKa2 | 13.31 | acidic |
| pKa3 | 3.1 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| D01687 | KEGG_DRUG |
| C0055017 | UMLSCUI |
| CHEBI:55488 | CHEBI |
| CHEMBL1689069 | ChEMBL_ID |
| C049934 | MESH_SUPPLEMENTAL_RECORD_UI |
| 5888 | INN_ID |
| 82219-81-6 | SECONDARY_CAS_RN |
| 860MT00T7T | UNII |
| 6336505 | PUBCHEM_CID |
Pharmaceutical products:
None